Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 191 - файл

.pdf
Скачиваний:
0
Добавлен:
28.08.2026
Размер:
98 Мб
Скачать
236
https://t.me/medicina_free
fondaparinux) or oral (dicumarol, warfarin, rivaroxaban); in vitro—heparin, sodium citrate, sodium oxalate and EDTA (Ethylene diamine tetra acetic acid). Contraindications for anticoagulant therapy: Ongoing bleeding; recent surgery/invasive procedure; severe trauma; bleeding tendency (clotting factor deficiency); intracranial haemorrhage; pericarditis/pericardial effusion; patient prone to fall.
Heparin (Unfractionated/UFH)
 It is a natural anticoagulant, a mucopolysaccharide. It
activates plasma antithrombin III and so blocks extrinsic
SRB’s Manual of Surgery
pathway. It has got antiplatelet action. It prevents clotting of blood both in vivo and in vitro by acting on all three stages of coagulation. It prolongs clotting time and activated thrombo­plastin time in specific (by 1.5–2.0 times the control).
 Heparin also causes hyperkalaemia, thrombocytopenia and
osteoporosis.
 Commercial heparin is derived from lung and intestinal
mucosa of pigs and cattle. The onset of action is immediate after administration lasting for 4 hours. It is metabolised in the liver by heparinase.
 It does not cross placental barrier and is not secreted in
breast milk.
Indications: As prophylaxis in major surgeries, postoperative
period, puerperium; as therapy in DVT; in vascular diseases.
Dose: For prophylaxis - 5,000 units/subcutaneously 8th
hourly. For therapy - 10,000 units/IV 6th or 8th hourly; later changed to subcutaneous dose. In severe cases, 5,000 units to 20,000 units is given daily through IV infusion at a rate of 1,000 units per hour. Daily dose should not exceed 25,000 units.
 Heparin should not be given intramuscularly and it is better
not to combine with penicillins, hydrocortisone. Heparin is not given orally. Heparin administration should always be monitored with APTT.
Complications: Allergy, bleeding, thrombocytopenia, alopecia,
osteoporosis.
Contraindications: Bleeding disorders, severe hyperten-
sion, GIT ulcer, piles, malignancy, ocular and neurosurgery, chronic alcoholism, cirrhosis, etc.
Note:
• Danaparoid is an antifactor Xa, heparinoid is an anticoagulant used in
patients where heparin is contraindicated.
• Heparin antagonist: 50 mg of 1% protamine sulphate solution is given
slow intravenous. 1 g reverses 100 units of heparin. It is given only after doing activated thromboplastin time. Overdosing or infusion without indication may itself precipitate bleeding.
Low Molecular Weight Heparin (LMWH)
 It is a commercially prepared heparin with a molecular weight
of 4,000 to 6,500.
 It acts by inhibiting factor Xa. It shows lesser antiplatelet
action and lower incidence of haemorrhagic complications. It has got better bioavailability on subcutaneous administra­tion (once daily).
Drugs are – Enoxaparin; Dalteparin; Parnaparin; Reviparin;
Fraxiparine. It is used as subcutaneous injection.
Uses: (1) Prophylaxis of DVT and Pulmonary embolism in
surgery, stroke and immobilized patients (2) DVT (3) myocar­dial infarction (4) Rheumatic heart disease (5) Haemodialysis patients.
Advantages: It has got longer duration of action once a day;
has better anticoagulant effect; less interaction with platelets; less antigenic; usage is easier and more acceptable; moni­toring is not necessary.
Disadvantages: They are expensive; only partially reversible
by protamine sulphate; it is monitored by anti-Xa assay which is not freely available.
Fondaparinux
 It is a synthetic pentasaccharide factor Xa inhibitor. It acts
by binding antithrombin III.
 Fondaparinux (Arixtra) is injected subcutaneously into the
abdominal wall as once daily dose (2.5 to 10 mg).
 It is used for initial treatment of deep vein thrombosis (DVT)
and pulmonary embolism (PE) and for prevention of venous thromboembolism in patients undergoing surgery for hip fracture or hip/knee replacement.
ORAL ANTICOAGULANTS
They are given orally and are slow-acting.
Types
Coumarin derivatives: Bishydroxycoumarin (Dicou marol):
First coumarin drug derived from sweet clover.
Warfarin sodium: Most common oral anticoagulant used.
 Indandione derivative: Phenindione, anisindione.
Mode of Action of Oral Anticoagulant Therapy
 By suppressing synthesis of prothrombin, factors VII, IX
and X.
 By inhibiting vitamin K mediated carboxylation of glutamic
acid.
 Oral anticoagulant does not have in vitro action.  They are slow-acting, and long-acting.  Control of oral anticoagulant therapy is by monitoring
prothrombin time.
 PT comes to normal only 7 days after cessation of the drug.
They cross placental barrier and are known to cause terato-
genicity when given in 1st trimester.
They are secreted in breast milk.
Indications
 In DVT after cessation of heparin for maintenance therapy.  After valve replacement surgery.
To achieve adequate anticoagulant effect and to prevent thromboembolic episodes the INR has to be maintained within 2–3.
Side Effects
https://t.me/medicina_free
 Bleeding—it may require blood transfusion/FFP or vitamin K
injection intramuscular or oral to control.
 Cutaneous gangrene.  Fetal haemorrhage and teratogenicity.  Alopecia, urticaria, dermatitis.  Drug interactions: with NSAIDs, cimetidine, omeprazole,
metronidazole, cotrimoxazole, ery thromycins, barbiturates, rifampicin, griseofulvin.
WARFARIN
WARFARIN (Wisconsin Alumni Research Foundation + coumARIN) derivative) SODIUM is the most common drug used. It has got lesser side effects. It has got cumulative action and so given in tapering dose.
Dose is 5 mg, once a day.
It should be discontinued 7 days before any surgery like tooth extraction and prothrombin time should return to normal level. During surgery, if excess bleeding occurs, fresh frozen plasma may be given.
The effects of warfarin sodium is reversed by injection vitamin K; the dose depends on INR and emergency of reversal (takes 24 times to reverse).
THROMBOLYTIC AGENTS
B
x Streptokinase; urokinase; anistreplase x Altepase - Recombinant tissue plasminogen activator (rtPA);
half life is 5 minutes; given as 10 mg IV bolus followed by 90 mg infusion in 90 minutes.
x Tenecteplase: genetically engineered, higher fibrin selectivity.
Differences between oral anticoagulants and heparin
T
Oral anticoagulant Heparin
Slow-acting Immediate Long-acting Short-acting Only in vivo action Both in vitro and in vivo action
Monitored by Prothrombin time Partial thromboplastin time
Crosses the placental barrier
Secreted in milk Not secreted in milk
Administration Orally Intravenously/subcutaneously
Does not cross the placenta
Non-vitamin K antagonist oral anticoagulants
(NOACs)
Direct thrombin inhibitors
¾
Recombinant hirudin and hirudin analogues—derived from leeches, are direct inhibitors of thrombin.
¾
Synthetic direct thrombin inhibitors (factor IIa) -Arga­troban, dabigatran etixilate (Pradaxa 110 mg).
Direct factor Xa inhibitors
¾
Rivaroxaban—It is given orally once or twice daily as 15–20 mg dose per day. It is given initially 15 mg twice daily, later 20 mg once daily. It shows rapid bioavailability; shows rapid onset of action; coagulation monitoring is not required. Apixaban (2.5 mg) and edoxaban are other
drugs. Contraindications for NOACs: Renal impairment; disorders of haemostasis; active bleeding; prosthetic heart valve; liver disease; pregnant and breastfeeding women; children less than 18 years.
Note:
Idarucizumab (Praxbind) is used to reverse the anticoagulant effects of dabigatran.
Reversal agents for apixaban and rivaroxaban are currently not available.
Antiplatelet Drugs
Small dose aspirin—inhibits platelet synthesis of thrombaxane A2. Ticlopidine (125 mg BD)—alters platelet membrane, thereby platelet aggregation. Clopidogrel—action similar to ticlopidine. Dextran—decreases platelet aggregation. Abciximab—glycoprotein IIb/IIIa inhibitors, block platelet aggre­gation, and platelet adhesion to fibrin. Dipyridamole—xanthine oxidase inhibitor.
PULMONARY EMBOLISM
 It is commonly due to lower limb DVT (15% of lower limb
DVT). It can also occur after pelvic vein DVT or upper limb DVT (30% of upper limb DVT).
 Chest pain, cough, haemoptysis, dyspnoea are the features.  Often site of DVT may be asymptomatic. When symptomatic,
fever, pain, tense, tender calf, with positive Homan’s sign may be evident.
 Massive embolism causes sudden cardiac arrest and death
due to pulmonary artery block. Moderate embolism causes pyramidal wedge-shaped infarcts in lungs.
 Duplex scan of limb, CT angiogram of thorax, pulmonary
angiogram (gold standard), X-ray chest, ventilation perfu­sion scan, ECG, echocardiography are useful investigations.
Treatment is thrombolysis, heparin/LMWH, compression
bandage.
 Occasionally surgical removal of clot from pulmonary artery
is done if possible.
IVC filter placement is essential in recurrent DVT with anti-
coagulation, DVT with contraindication for anticoagulation, pulmonary hypertension. Greenfield IVC filter is ideal with 95% patency rate. Complications are—bleeding, haematoma, migration of filter into pulmonary artery, thrombosis at filter level, IVC perforation.
Retrievable IVC filters are newer method used to prevent long-
term filter complications. It is used in young patients who
237
CHAPTER 1N General Surgery: Venous Diseases
Attitudes are more important than facts.
238
https://t.me/medicina_free
are at risk of DVT and embolism, for short specified period only like—high-risk trauma with orthopaedic injuries, exten­sive iliofemoral thrombosis, during thrombolytic therapy.
Recovery filter, Gunthur-Tulip filter, Opt
Ease filters are
used. They are deployed through IJV or femoral vein under
Gunthur-Tulip types are recovered through right IJV. OptEase is recovered from right femoral vein. Complications are same as nonretrievable IVC filters. Retrieval failure, retrieval site thrombosis and embolism are specific complications.
 DVT prophylaxis is a must in all these patients.
angiographic or intravascular US guidance. Recovery and
VENOUS THROMBO EMBOLISM (VTE)
B
x VTE can be provoked (with identifiable causes) or unprovoked (no identifiable causes) x Acute dyspnoea, chest pain, haemoptysis, later haemodynamic instability, shock, RV dysfunction are the features. High, moderate and low
risk groups are identified. Wells and modified Geneva criteria are used.
SRB’s Manual of Surgery
x CT angiogram is diagnostic. D dimer/duplex Doppler US of leg, MRI pelvis, coagulation profile, chest X-ray are other needed investigations x Treatment modalities—anticoagulants, thrombolysis, percutaneous interventions, surgery
– Anticoagulants (Heparin) are used in pulmonary embolism without haemodynamic instability or without right ventricular dysfunction – Thrombolysis—Indications: Pulmonary embolism with haemodynamic instability with right ventricular dysfunction or instability in spite
of heparin therapy or with intracavitary right heart thrombi/massive embolism. Thrombolysis dissolves the thrombus obstructing the pulmonary artery; prevents the release of neurohumoral factors and serotonin which causes pulmonary arterial hypertension (PAH); reverses right heart failure; dissolves venous thrombus in periphery. Thrombolysins used are—streptokinase (loading dose is 2,50,000 units IV; continuous infusion of 1, 00,000 units/hour for 24 hours), urokinase (loading dose 2000 units/lb infused IV in 10 minutes, continuous infusion IV 2000 units/lb/hour for 24 hours), tissue plasminogen activator (tPA is ideal)—alteplase continuous infusion 100 mg/2 hours, reteplase bolus IV 10 units in every 30 minutes, tenectplase, desmoteplase. Contraindications for thrombolysis—stroke, brain tumour, bleeding disorders, major trauma/surgery, recent GI bleed, pregnancy, endocarditis, advanced liver disease
– Percutaneous catheter fragmentation of clots and thrombolysis using pigtail catheter/clot buster/angio jet – Retrievable IVC filters are used commonly now. Permanent filters are used only in—high risk group, risk of recurrent embolism, life
expectancy less than 6 months
x Venous thrombosis/VTE in pregnancy is more common with 2/1000 pregnancies with 5 times more in postnatal period. It is 90% left
side mainly proximal. Left calf asymmetry with >2 cm in 1st trimester with features of embolism. Calf and thigh US for leg DVT and MRI for pelvic DVT should be done. Echocardiography should be done to check embolism; chest X-ray with abdominal shield may be needed. LMWH should be given. Warfarin (crosses placenta), rivaroxaban are avoided. TPA crosses the placenta but is used in massive pulmo­nary embolism with haemodynamic instability as life-saving often along with embolectomy. LMWH is given throughout the pregnancy; stopped peridelivery period; continued postnatal period for 1 month with 75% of earlier dose; later compression stockings and warfarin for 6 months. Compression stockings, hydration, ambulation, left lateral position are preventive measures in pregnancy often along with LMWH if needed/indicated.
x ACCP guidelines 2012 for VTE therapy:
– Initial phase up to 7 days—UFH/LMWH/Fondaparinux/rivaroxaban; – Long-term up to 3 months—LMWH/rivaroxaban/dabigatran/VKA with INR 2–3 range (optimum 2.5); Extended is beyond 3 moths—VKA/rivaroxaban/dabigatran/LMWH if needed
VENOUS TUMOURS
B
x Venous tumours are rare. x Venous malformations usually considered under this which includes arteriovenus malformations, haemangomas also. It can occur anywhere
in the body from skin to deeper structures.
x Leiomyoma and leiomyosarcoma of the venous wall can occur. It is slow growing lesion presenting as mass with pain with venous obstruc-
tion features with oedema distally. Dilated veins are often obvious. MRI and FNAC confirm the diagnosis. Treatment is wide excision with the involved vein. If vein is major one, then resected vein should be reconstructed with prosthetic graft (example—IVC).
O. Lymphatics
https://t.me/medicina_free
C hapter Outline
·
Surgical Anatomy
·
Lymphangiography
·
Isotope Lymphoscintigraphy
·
Acute Lymphangitis and Lymphadenitis
·
Lymphoedema
·
Lymphomas
x Hodgkin’s
Lymphoma
x
Non-Hodgkin’s Lymphoma
SURGICAL ANATOMY
Primordial lymphatic system begins to develop during 6th week of development adjacent to jugular vein as lymph sacs. Peripheral lymphatic systems develop from these primordial lymph sacs. Lymphatic system has three components. Terminal lymphatic capillaries, which have high porosity absorb lymph, macromolecules, cells and microbes from tissues into the system; lymphatic vessels which collect and transport lymph; lymph nodes which are interposed in the lymphatic pathway filter lymph and maintain immunity of the body. Lymphatic vessels run adjacent to main blood vessels reaching the major lymphatic channels. Cisterna chyli is formed in the abdomen, continues as thoracic duct (formed at 9th week of gestation) in the thorax which has got initial main course towards right side of the mediastinum; but later towards left side entering the internal jugular vein at its joining point of the subclavian vein. In the periphery, there is hardly any lymphovenous communications. Lymphovenous communications occur at lymph node level; iliac, subclavian and jugular levels. Lymphatics are absent in epidermis, cornea, CNS, cartilage, tendon and muscle.
Great lymph ducts are—the thoracic duct—single; right lymph duct—single; subclavian, bronchomediastinal and jugular trunks on both sides. These ducts contain valves to prevent backflow.
Cisterna chyli is formed by joining of right and left lumbar lymphatic trunks and intestinal lymphatic duct. Lumbar trunks are short lymph vessels arising from para-aortic lymph glands. It receives lymph from lower limb, pelvis and pelvic viscera, kidney, adrenal and deep lymphatics of abdominal wall. Left lumbar trunk is behind the aorta. Intestinal lymph duct arises from preaortic nodes. It joins the cisterna chyli from front. It
·
Mantle Cell Lymphoma
·
Malt Lymphoma (Maltoma)
·
Burkitt’s Lymphoma
·
Cutaneous T Cell Lymphoma
·
Chylous Ascites
·
Chylothorax
·
Chyluria
·
Sarcoidosis
receives lymph from stomach, intestines, liver (except most convex surface which drains into right lymph duct), spleen and pancreas. Cisterna chyli is a lymph sac lying in front of
and L2 vertebrae between aorta and crus of the diaphragm.
the L
1
From its upper end it continues as thoracic duct. Thoracic duct passes through the aortic orifice of the diaphragm, runs medial to azygos vein and right of the aorta in posterior mediastinum. In front it is related to oesophagus, diaphragm and pericardium; behind right intercostal arteries, hemiazygos and accessory hemiazygos vein. At the level of 7th thoracic vertebra, it crosses towards left side behind the oesophagus obliquely reaching left side at 5th thoracic vertebral level. It runs upwards between left margin of oesophagus, medial part of left pleura, and behind left subclavian artery. In the neck, it passes in front of vertebral system (vertebral vessels and sympathetic chain) and behind carotid system (Common carotid artery, internal jugular vein, vagus nerve), crossing scalenus anterior, phrenic nerve, trans­verse cervical and suprascapular arteries ending as a single vessel at the junction of internal jugular vein and subclavian vein with a valve. Tributaries of thoracic duct are—trunk from lateral intercostal nodes from lower six spaces; efferents from posterior
Fig. 1.4 31: Thoracic duct anatomy; cisterna chyli; tributaries of
thoracic duct.
In very early oedema, during pinching, there is a resistance that is not present on normal site,
owing to thickening of dermis and subcutaneous tissue. —Sidney S Rose
240
https://t.me/medicina_free
SRB’s Manual of Surgery
Fig. 1.4 32: Watershed zones/areas of lymphatic drainage. Vertical sagittal midline; clavicular horizontal line; umbilical line—are used to divide areas into three zones on each side. Above clavicular line drainage occurs to cervical nodes; between clavicular line and umbilical line drainage occurs into axillary nodes; below umbilical line drainage occurs to inguinal lymph nodes. At the level of (lines) drainage can occur to lymph nodes on either side.
mediastinal nodes, lateral intercostal nodes of upper six spaces, left jugular lymph trunk from head and neck region, left subcla­vian lymph trunk from left upper limb, left bronchomediastinal trunk from left side of the thorax. Single termination of duct is common (77%); but double/triple/quadruple terminations are known to occur. Occasionally it may end in left subclavian vein, left vertebral vein, right internal jugular vein, right subclavian vein. Thoracic duct is 45 cm in length and 5 mm wide (wider at both ends; narrow in the middle).
Right lymph duct is 2.5 cm in length, formed by right jugular, right subclavian and right bronchomediastinal trunks; runs on the scalenus anterior joining the junction of right internal jugular vein and subclavian vein.
There are about total 450–600 lymph nodes in the body. Around 200 in the neck; around 100 in the thorax; around 50–60 in the axilla; around 250 in the abdomen and pelvis; around 50 in the groin area.
cytic aggregations of primary follicles or lymphocytic aggregation with germinal centres of secondary follicles due to antigenic stimula­tion. It contains B lymphocytes, macrophages, dendritic reticulum cells. Germinal centre is surrounded by small B lymphocytes. Both cortex and medulla are associated with humoral immunity. Prolif­eration of germinal centres suggests active humoral immunity with antibody production. Central medulla contains mainly lymphatic sinuses, arteries and veins, plasma cell and B lymphocytes. Para­cortex is located in a zone between cortex and medulla. It contains T lymphocytes, related to cell mediated immunity. Post-capillary venules with high endothelial cells and lymphocytes in the wall are typical. In cell mediated immunity, paracortex expansion occurs. Afferent lymph vessels enter the node through the capsule. It enters the marginal sinus, communicates with intranodal sinus, merging as efferent lymph vessels which enter the hilum. Intranodal sinus lining is highly phagocytic containing littoral cells and sinus lining histiocytes. Main artery and veins pass through the hilum to enter the medulla, paracortex and inner part of cortex. Superficial cortex is supplied by direct capsular vessels.
Function of Lymphatics
Most of the intravascular proteins are daily filtered through lymphatics and returned to the circulation again. Macromol-
ecules (albumin, globulin and fibrinogen) and microbes are also filtered at the nodal level as first immune system. From GIT fat is absorbed directly through lymphatics. Lymph shows centripetal flow. Cholesterol, long chain fatty acids, fat soluble vitamins are transferred through lymphatics into cistern chyli directly from GIT bypassing the liver. Transport is mainly due to intrinsic contractility of the lymphatic vessels which contain valves for effective forward flow. To a lesser extent other factors like muscle contraction, arte­rial pressure, thoracic pressure, respiratory movements play role.
8 litres of lymph is produced daily; once it reaches to lymph nodes it is concentrated to 4 litres which enters the venous circulation. Protein concentration in lymph is very high (25 grams/litre).
Note:
Lymph drains protein rich fluid; there are no communicating/perforator lymphatics; lymphatics will not regenerate
Lymphatic Watersheds of Skin
Lymph from the dermis and appendages drain into a plexus in deep fascia which in turn drains into respective lymph nodes. There are six watershed areas in the body for lymphatic drainage. One vertical midline divides into right and left. Two horizontal lines on each side divide the area into three zones. First lies above the line of clavicle; second between line of clavicle and line at umbilical level; third below the level of umbilical line. First drains into head and neck lymph nodes; second drains into axillary nodes; third drains into inguinal/groin nodes. Malignancy drains into their respective nodes depending on the location. Lesion on the line can spread to both territory lymph nodes. In skin and appendageal cancers, deep fascia also should be cleared.
Microanatomy of Lymph Node
Lymph node contains three regions—cortex; paracortex and medulla. Cortex contains mainly follicles. It may be rounded lympho-
LYMPHANGIOGRAPHY
Indications
 Congenital lymphoedema like aplasia, hypoplasia, hyper-
plasia.
 Lymphomas show reticular pattern. It is also useful to assess
the response to treatment.
 Secondaries in lymph nodes, especially iliac and para-aortic
lymph nodes.
Technique
 Patent blue dye or 1 ml isosulphan blue is injected subcuta-
neously between toes. Dye is taken up by lymphatics which will be visualised clearly. After making incision, one of the lymphatic vessels is dissected and 30 G needle is passed. Ultra-fluid lipiodol which is an oily contrast medium is
injected slowly using pressure pump at a rate of 1 ml in 8
https://t.me/medicina_free
minutes (total quantity is 7 ml). Slowly in 24 hours, it passes
through the lymphatics and reaches the iliac and para-aortic
lymph nodes. Radiographs taken will help to visualise both
lymphatic vessels as well as lymph nodes.
 Secondaries in lymph nodes causes filling defects.
Lymphomas shows enlarged nodes which have foamy or
reticular appearance.
Disadvantages: Technically difficult; Extravasation of dye can
occur; Dye may not reach the required area; Time consuming
and invasive procedure.
Lymphangiographic classification of lymphoedema (Browse clas­sification): (Norman Browse)
Congenital hyperplasia (10%): Congenital; common in males;
entire leg is involved; one or both sides; with often family history; progressive; involves increased number of lymphatics and lymph nodes associated with chylous ascites, chylothorax and protein losing enteropathy
Distal obliteration (80%): Common in females; starts at puberty;
calf and ankle are involved; often bilateral; with often family history; slow progression; aplasia/hypoplasia of lymphatics
Proximal obliteration (10%): Occurs at any age; equal in both
sexes; leg and thigh involved; unilateral; rapid progression; proximal aortoiliac nodal block
ISOTOPE LYMPHOSCINTIGRAPHY
This test gives a qualitative assessment of the lymphatic
function. Quantitative measure is done to assess lymphatic
transfer by dynamic component to static part.
 Radioactive technetium labelled sulphide colloid particles,
or radioiodinated human albumin are injected into the web
space using fine needle. These particles are specifically taken
up by lymphatics.
 Using gamma camera, limb and inguinal region is exposed to
visualise the lymphatics and inguinal lymph nodes.
 Radioactivity in inguinal nodes is measured at 30 and 60
minutes. Normal uptake is 0.6–1.6%; if it is <0.3% in 30
minutes it is diagnostic of lymphoedema. If it is >2% it
suggests rapid abnormal clearance due to oedema as the
result of venous disease.
 In 3 hours, it reaches the para-aortic lymph nodes, other
abdominal lymph nodes and liver.
 Later thoracic duct also can be visualised. It can be compared
to the take up on the other limb.
 Advantages:
¾
It is more sensitive.
¾
Technically easier and faster compared to lymphangi­ography.
¾
Thoracic duct, other lymph nodes and liver can be visu­alised.
¾
It is the test of choice. It is simple and safe.
¾
It has 90% sensitivity; 100% specificity.
ACUTE LYMPHANGITIS AND LYMPHADENITIS
 Acute inflammation of the lymphatics occurs after bacterial
infection like Streptococcus pyogenes and Staphylococcus aureus. It is common infective condition especially in limbs. Condition is often associated with cellulitis.
Fig. 1.4 33: Acute lymphangitis leg. Usually regional lymph
nodes are enlarged and tender.
 Diffuse swelling in the skin with redness which blanches on pres-
sure is typical. Fever, chills, pain and tenderness are common.
 Regional lymph nodes often get infected causing palpable
tender lymph nodes as acute lymphadenitis; abscess in the area can occur which may require often incision and drainage.
 Minor trauma, lymphoedema are precipitating factors.  Infection spreads faster especially in diabetics and immuno-
suppressed people often leading into septicaemia.
 Deep vein thrombosis, cellulitis are differential diagnosis.  Total count will be raised; blood sugar should be assessed.
Ultrasound with venous Doppler is done.
Treatment: Antibiotics oral or intravenous; limb elevation;
glycerine magnesium sulphate local application; anti-inflam­matory drugs are needed to treat. If suppuration occurs then incision and drainage or fasciotomy with wound debridement is required. Large raw area if develops may require split skin grafting to cover. If septicaemia develops critical care treat­ment is required after admission.
 Recurrent infection; development lymphoedema; septicaemia;
lymphadenitis – are complications.
LYMPHOEDEMA
It is accumulation of fluid (lymph) in extracellular and extravas­cular fluid compartment, commonly in subcutaneous tissue. It is primarily due to defective lymphatic drainage.
It is increased protein rich interstitial fluid.
241
CHAPTER 1O General Surgery: Lymphatics
Don’t consume your tomorrow’s feeling on your yesterday.
242
https://t.me/medicina_free
Classication
Kinmonth classified lymphoedema as:
 Primary without any identifiable lymphatic disease.  Secondary is acquired due to definitive cause. Most common
form.
PRIMARY TYPE
B
It affects commonly females.
 It is common in lower limb and left side.
It can be:
 Familial  Syndromic (Turner’s/Klinefelter’s/Down’s/Klipple Trenauny
SRB’s Manual of Surgery
Weber)
It can be:
 Lymphoedema — Present at birth—<2 years
congenital (10%) — Familial type is called as Nonne-Milroy’s disease. It is type I
 Lymphoedema — Present at puberty—up to 2–35 years (80%).
praecox — Familial type is called as Letessier-Meige’s
 Lymphoedema — Present in adult life—after 35 years
tarda
It can be radiologically (lymphangiography):
 Hypoplasia 70%  Aplasia 15%  Hyperplasia (varicose lymphatics) 15%
Fig. 1.4 34: Right side congenital limphoedema in a girl.
familial, autosomal dominant—chromo­some 5 related; bilateral upper and lower limbs, genitalia and face may be involved. Incidence is 1:6000 of live births.
syndrome. It is type II familial. It occurs between puberty and middle age.
Fig. 1.4 35: Early lymphoedema left side—pitting type.
Pathophysiology of Lymphoedema
Decreased lymphatic contractility, lymphatic valvular insuf­ficiency, lymphatic obliteration by infection, tumour or surgery causes all effects and pathology of lymphoedema. This leads to lymphatic hypertension and dilatation causing lymph stasis, accumulation of proteins, glycosamines, growth factors, and bacteria. There is more collagen formation, deposition of proteins, fibroblasts, ground substance causing fibrosis in subcutaneous and outside deep fascia. Muscles are normal without any oedema but may get hypertrophied.
CAUSES OF SECONDARY LYMPHOEDEMA
B
 Trauma  Surgery—inguinal block or axillary block dissection/post-
mastectomy with axillary clearance
 Filarial lymphoedema due to Wuchereria bancrofti—common
cause in coastal region
 Tuberculosis, Syphilis, Fungal and Bacterial infection  Advanced malignancy—hard, fixed lymph nodes in axilla or in
inguinal region
 Postradiotherapy lymphoedema  Rare causes: Rheumatoid arthritis, snake and insect bites, DVT,
chronic venous insufficiency
Note:
Secondary lymphoedema develops rapidly.
Fig. 1.4 36: Late lymphoedema—grade 2.
Filariasis
It is caused by a parasite Wuchereria (Brazil) Bancrofti (Australia). It was also called as Malabar leg in 1709, by Clarke,
Cochin. Female adult worm is longer 7–10 cm than male worm (4 cm). Microfilaria is colourless, translucent, 300 µ length and 10 µ thick. It has head, body and tail. Microfilaria circulates in blood. In India, Asian countries and China, they show nocturnal periodicity (from 10 PM to 4 AM). It is related to night biting habits of the vector, Culex fatigans mosquito and sleeping habits of the host.
Man is the definitive host; animal or reservoir host is not known. Female mosquito is intermediate host (in India and China—Culex fatigans). Development or multiplication of micro-
filaria will never occur in human blood. Life span of microfilaria
https://t.me/medicina_free
in human blood is 3
months. Microfilaria is infective to female mosquito. A density of 15 microfilaria/drop of blood are needed to make it infective.
Fig. 1.4 37: Lymphoedema leg extending into the thigh with
lymphangitis.
A
stage larva in one week elongated actively motile third stage infective larva in one more week (one microfilaria forms one
infective larva; microfilaria never multiplies in mosquito nor in human) enters the proboscis of mosquito to become infective to human during the mosquito bite; it takes 20 days for microfilaria to develop into infective 3rd stage larva in mosquito [extrinsic incubation period] enters human skin while biting many larvae get destroyed in human skin by immunity, few enters lymphatics enters regional lymph nodes in inguinal or axillary or abdominal nodes develop into adult worm in lymph nodes mating of female and male worms takes place gravid female worm releases up to 50,000 microfilariae/day into lymph circulation thoracic duct subclavian vein microfilaria in human circulation infective to female mosquito. Time from 3rd stage infective larva entering human skin and forming adult worm and later releasing microfilaria into blood is called as biological incuba- tion period (12 months); time from 3rd stage infective larva entering human skin to appearance of first clinical feature is called as clinical incubation period (16 months).
Effects of Wuchereria Bancrofti Infection
 Carrier stage having circulating microfilaria but asympto-
matic.
 Immune and allergic reactions by adult worm causing
macrophage and lymphocyte infiltration, endothelial hyperplasia, lymphatic vessel wall thickening, lymph stasis, dilatation, further reaction, fibrosis, further blockage, calcification, recurrent streptococcal infection, filarial lymphoedema.
 Filarial fever, utricaria, pruritus, epididymo-orchitis as acute
presentation.
Occult filariasis where microfilaria is not demonstrable in
blood but identified in lungs (by biopsy confirmation) causing eosinophilia, bronchospasm, nocturnal cough, fever, wheeze, weight loss, arthritis, thrombophlebitis, tenosynovitis.
 Lymphadenitis, lymphangitis.  Lymphangiovarix, lymphorrhagia, lymph scrotum,
lymphocele, chyluria, chylous diarrhoea, retroperitoneal
lymphangitis, chylous ascites, chylothorax.
Blood smear—night time (thick and thin), lymph node biopsy,
skin test, eosinophilia, serological tests, DEC provocation test (by giving 100 mg DEC) are different investigations.
243
CHAPTER 1O General Surgery: Lymphatics
B
Figs. 1.438A to C: Lymphoedema foot in different patients—severe
with vesicles/oedema/skin changes/fissures.
Life Cycle
Microfilaria from carrier human blood enters the stomach of female Culex mosquito when it bites human carrying the parasite in blood ex-sheathing of microfilaria in stomach of mosquito in 6 hours penetrate the stomach wall migrate to thoracic muscles of mosquito in 12 hours metamorphosis into sausage shaped first stage larva in 48 hours second
C
PATHOLOGY (COMMONLY IN FILARIAL LYMPHOEDEMA)
B
Recurrent lymphangitis causes obliteration of lymph vessels
Dermal lymphatic backflow
Retrograde obliteration (or die back of lymphatics)
Oedema, initially pitting but later nonpitting
Recurrent cellulitis—thickening of skin
Contd...
Knowledge speaks, but wisdom listens.
244
https://t.me/medicina_free
Contd...
Accumulation of proteins, growth factor, glycosaminoglycans
Activation of collagens and keratinocytes
Protein rich lymphoedematous tissue formation
Deposition of ground substance, subdermal fibrosis
Dermal thickening and dermal proliferation, Fissuring Cracks—
Ulceration—Abscess formation
SRB’s Manual of Surgery
Stout leg with unbearable weight
Elephantiasis.
Rarely it causes protein losing diarrhoea, chylous ascites, chylothorax, chyluria, lymphorrhoea. Recurrent lymphadenitis occurs in the region which aggravate the condition.
Disease in the limb is confined to skin and subcutaneous tissue, i.e. often, only superficial lymphatics are involved by the disease, deep lymphatics are not. Superficial and deep lymphatics are not communicating with each other (Unlike the veins in the limb where superficial and deep veins are freely communicating with each other).
SITES OF LYMPHOEDEMA
B
 Lower limb—most common  Upper limb, Scrotum, penis (Ram’s horn penis)  Breast—requires reduction mammoplasty  Labia, Eyelid  Localised lymphoedema
A
B
Figs. 1.439A and B: Different lymphoedema pictures. Note the oedema,
fissuring, cracks. All these make it more vulnerable for infection.
Clinical Features
Swelling in the foot, extending progressively in the leg—tree
trunk pattern leg.
Loss of normal perimalleolar shape—tree trunk pattern leg.  Buffalo hump in the dorsum of the foot; Squaring of toes.
 Skin over the dorsum of foot cannot be pinched because of
subcutaneous fibrosis—Stemmer’s sign.
 Initially pitting oedema occurs, which later becomes nonpit-
ting.
 Dull ache/severe pain/burning/bursting/cramps; 50% patients
will have pain.
 Debility/immobility/obesity/muscle wasting.  Athlete’s foot with joint pain and disability.  Eczema, fissuring, papillae formation, ulceration, lymph ooze,
elephantiasis are other features.
 Fever, malaise, headache; Recurrent abscess formation.
 Psychological and social discomfort causing severe morbidity.
Endemic elephantiasis/podoconiosis is common in Africa;
seen in barefoot workers; due to destruction of lymphatics
by silica derived from soil containing alkaline volcanic
rocks.
Fig. 1.4 40: Lymphoedema of lower limb developed after ilioinguinal
block dissection for nodal secondaries from melanoma.
Fig. 1.4 41: Recurrent filarial leg with nodules and ulceration.
Fig. 1.4 42: Extensive scrotal lymphoedema of filarial origin. Patient
https://t.me/medicina_free
underwent scrotal reduction.
245
CHAPTER 1O General Surgery: Lymphatics
B
Figs. 1.444B
Figs. 1.444A and B: Lymphoedema of penis. It needs reduction and
reconstruction otherwise it may cause urinary problem and sexual dysfunction.
Fig. 1.4 4 3: Lymphoedema right forearm. Common causes for upper limb lymphoedema are filarial and post-mastectomy with axillary nodal clearance.
A
Fig. 1.444A
Indecisive people are like a blind man looking in a dark room for a black cat that isn’t there.
Fig. 1.4 4 5: Severe lymphoedema foot with vesicles and thickening.
BRUNNER’S GRADING OF LYMPHOEDEMA
B
Latent—subclinical: No clinically apparent lymphoedema. Grade I
Pitting oedema which more or less disappears on elevation
of the limb—is due to excess deposition of interstitial fluid
Nonpitting oedema occurs which does not reduce on
Grade II
elevation
Grade III
B
Oedema with irreversible skin changes like fibrosis,
papillae, fissuring
LYMPHOEDEMA CAN BE
 Mild lymphoedema—<20% of excess limb volume.  Moderate lymphoedema—20—40%.  Severe lymphoedema—>40%.
Differential Diagnosis
 Cardiac causes, hypoproteinaemia, malnutrition, nephrotic
syndrome, liver failure.
 Myxoedema, Trauma, Venous diseases like DVT.